Literature DB >> 32463627

Opioid use trends in patients undergoing elective thoracic and lumbar spine surgery.

Alexandra Stratton1, Eugene Wai1, Stephen Kingwell1, Philippe Phan1, Darren Roffey1, Mohamed El Koussy1, Sean Christie1, Peter Jarzem1, Parham Rasoulinejad1, Steve Casha1, Jerome Paquet1, Michael Johnson1, Edward Abraham1, Hamilton Hall1, Greg McIntosh1, Kenneth Thomas1, Raja Rampersaud1, Neil Manson1, Charles Fisher1.   

Abstract

Background: Opioid use in North America has increased rapidly in recent years. Preoperative opioid use is associated with several negative outcomes. Our objectives were to assess patterns of opioid use over time in Canadian patients who undergo spine surgery and to determine the effect of spine surgery on 1-year postoperative opioid use.
Methods: A retrospective analysis was performed on prospectively collected data from the Canadian Spine Outcomes and Research Network for patients undergoing elective thoracic and lumbar surgery. Self-reported opioid use at baseline, before surgery and at 1 year after surgery was compared. Baseline opioid use was compared by age, sex, radiologic diagnosis and presenting complaint. All patients meeting eligibility criteria from 2008 to 2017 were included.
Results: A total of 3134 patients provided baseline opioid use data. No significant change in the proportion of patients taking daily (range 32.3%-38.2%) or intermittent (range 13.7%-22.5%) opioids was found from pre-2014 to 2017. Among patients who waited more than 6 weeks for surgery, the frequency of opioid use did not differ significantly between the baseline and preoperative time points. Significantly more patients using opioids had a chief complaint of back pain or radiculopathy than neurogenic claudication (p < 0.001), and significantly more were under 65 years of age than aged 65 years or older (p < 0.001). Approximately 41% of patients on daily opioids at baseline remained so at 1 year after surgery.
Conclusion: These data suggest that additional opioid reduction strategies are needed in the population of patients undergoing elective thoracic and lumbar spine surgery. Spine surgeons can be involved in identifying patients taking opioids preoperatively, emphasizing the risks of continued opioid use and referring patients to appropriate evidence-based treatment programs.
© 2020 Joule Inc. or its licensors.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32463627      PMCID: PMC7829003          DOI: 10.1503/cjs.018218

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  22 in total

1.  Chronic Opioid Usage in Surgical Patients in a Large Academic Center.

Authors:  Xueying Jiang; Margaret Orton; Rui Feng; Erik Hossain; Neil R Malhotra; Eric L Zager; Renyu Liu
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

2.  Incidence and Risk Factors for Chronic Postoperative Opioid Use After Major Spine Surgery: A Cross-Sectional Study With Longitudinal Outcome.

Authors:  Lauren K Dunn; Sandeep Yerra; Shenghao Fang; Mark F Hanak; Maren K Leibowitz; Siny Tsang; Marcel E Durieux; Edward C Nemergut; Bhiken I Naik
Journal:  Anesth Analg       Date:  2018-07       Impact factor: 5.108

3.  Preoperative opioid use and its association with perioperative opioid demand and postoperative opioid independence in patients undergoing spine surgery.

Authors:  Sheyan J Armaghani; Dennis S Lee; Jesse E Bible; Kristin R Archer; David N Shau; Harrison Kay; Chi Zhang; Matthew J McGirt; Clinton J Devin
Journal:  Spine (Phila Pa 1976)       Date:  2014-12-01       Impact factor: 3.468

4.  Hyperalgesia induced by low-dose opioid treatment before orthopaedic surgery: An observational case-control study.

Authors:  Nabil Hina; Dominique Fletcher; Frédérique Poindessous-Jazat; Valéria Martinez
Journal:  Eur J Anaesthesiol       Date:  2015-04       Impact factor: 4.330

5.  Opioid therapy for chronic noncancer back pain. A randomized prospective study.

Authors:  R N Jamison; S A Raymond; E A Slawsby; S S Nedeljkovic; N P Katz
Journal:  Spine (Phila Pa 1976)       Date:  1998-12-01       Impact factor: 3.468

6.  Preoperative Opioid Use as a Predictor of Adverse Postoperative Self-Reported Outcomes in Patients Undergoing Spine Surgery.

Authors:  Dennis Lee; Sheyan Armaghani; Kristin R Archer; Jesse Bible; David Shau; Harrison Kay; Chi Zhang; Matthew J McGirt; Clinton Devin
Journal:  J Bone Joint Surg Am       Date:  2014-06-04       Impact factor: 5.284

7.  Prolonged Preoperative Opioid Therapy Associated With Poor Return to Work Rates After Single-Level Cervical Fusion for Radiculopathy for Patients Receiving Workers' Compensation Benefits.

Authors:  Mhamad Faour; Joshua T Anderson; Arnold R Haas; Rick Percy; Stephen T Woods; Uri M Ahn; Nicholas U Ahn
Journal:  Spine (Phila Pa 1976)       Date:  2017-01-15       Impact factor: 3.468

8.  Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain.

Authors:  Gary J Vorsanger; Jim Xiang; Theophilus J Gana; Maria Luz G Pascual; R Rosanna B Fleming
Journal:  J Opioid Manag       Date:  2008 Mar-Apr

9.  A minimum of 5-year follow-up after lumbar transforaminal epidural steroid injections in patients with lumbar radicular pain due to intervertebral disc herniation.

Authors:  David J Kennedy; Patricia Z Zheng; Matthew Smuck; Zachary L McCormick; Lisa Huynh; Byron J Schneider
Journal:  Spine J       Date:  2017-09-28       Impact factor: 4.166

Review 10.  Systemic Pharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline.

Authors:  Roger Chou; Richard Deyo; Janna Friedly; Andrea Skelly; Melissa Weimer; Rochelle Fu; Tracy Dana; Paul Kraegel; Jessica Griffin; Sara Grusing
Journal:  Ann Intern Med       Date:  2017-02-14       Impact factor: 25.391

View more
  1 in total

1.  The potential for diversion of prescribed opioids among orthopaedic patients: Results of an anonymous patient survey.

Authors:  Kala Sundararajan; Prabjit Ajrawat; Mayilee Canizares; J Denise Power; Anthony V Perruccio; Angela Sarro; Luis Montoya; Y Raja Rampersaud
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.